Guided Therapeutics (GTHP) Ending Cash Balance (2009 - 2026)
Guided Therapeutics' Ending Cash Balance came in at $731,000 for Q3 2023, down 72.9% from $2.7 million a year earlier and down 46.2% from the prior quarter.
Guided Therapeutics (GTHP) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2022, Guided Therapeutics' Ending Cash Balance was $2.31 million, up 259.7% from FY2021.
- Ending Cash Balance carries a five-year compound annual growth rate of 370.8% (FY2017 to FY2022).
- Going back by year, Ending Cash Balance was $643,000 in FY2021 (+253.3%), $182,000 in FY2020 (-79.8%) and $899,000 in FY2019.
- The Q3 2023 figure represents the lowest quarterly Ending Cash Balance since Q2 2022.
- Year-over-year, Ending Cash Balance increased in five of the last eight quarters, with growth averaging 137.9%.
- The fastest year-over-year change in Ending Cash Balance over five years came in Q3 2022 (growth of 398.5%), and the weakest in Q1 2019 (a decline of 92.1%).
- Business Quant data shows GTHP's Ending Cash Balance at $1.36 million (Q2 2023), $1.84 million (Q1 2023) and $2.31 million (Q4 2022) in the three quarters before Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 5.49 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 4.05 Bn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 5.68 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 3.02 Bn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | 3.27 Bn |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 797.00 Mn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 3.11 Bn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 2.32 Bn |
| 10 | Guided Therapeutics | 10,618.96 | -520,381.04 | - | 12,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 275,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 591,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 725,000.00 |
| Dec 31, 2021 | 643,000.00 |
| Sep 30, 2021 | 541,000.00 |
Guided Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GTHP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "GTHP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GTHP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();